Kamada (KMDA) Revenue Growth (3y) (2015 - 2026)
Kamada (KMDA) Revenue Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 23.10 Bn | 20.95 Bn | 648.10 Mn | 15.52% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 2.94% |
| 10 | Kamada | 402.37 Mn | 329.22 Mn | 19.12 Mn | -88.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88.62% |
| Dec 31, 2025 | -0.56% |
| Sep 30, 2025 | -88.66% |
| Jun 30, 2025 | 1,137.94% |
| Mar 31, 2025 | 16.15% |
| Dec 31, 2024 | 7.42% |
| Sep 30, 2024 | 21.92% |
| Jun 30, 2024 | 1,105.58% |
| Mar 31, 2024 | 14.86% |
| Dec 31, 2023 | 4.92% |
| Sep 30, 2023 | 2.40% |
| Jun 30, 2023 | 4.21% |
| Mar 31, 2023 | 873.47% |
| Dec 31, 2022 | 12.32% |
| Sep 30, 2022 | 891.37% |
| Jun 30, 2022 | -12.53% |
| Mar 31, 2022 | 1.59% |
| Dec 31, 2021 | -13.25% |
| Sep 30, 2021 | 15.43% |
| Jun 30, 2021 | -10.53% |